These compounds may interact with:
Apoptotic protease-activating factor 1
Potentially involved in: kidney cancer; carcinoma; cancer; renal cell carcinoma; carcinoma, transitional cell; eye abnormalities; liver cirrhosis, experimental; retinal detachment; skin abnormalities; unipolar depression; craniofacial abnormalities; major depressive disorder; adrenocortical carcinoma; group 3 medulloblastoma; hepatocellular carcinoma; intraductal papillary-mucinous adenoma (ipma); intraductal papillary-mucinous neoplasm (ipmn); osteosarcoma; pancreatic cancer; pancreatic carcinoma
Disease data sourced from Pharos.